These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 26940560)

  • 1. The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?
    Dézsi CA
    Am J Cardiovasc Drugs; 2016 Aug; 16(4):255-266. PubMed ID: 26940560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
    Verdecchia P; Gentile G; Angeli F; Reboldi G
    Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination.
    Bomback AS; Toto R
    Am J Hypertens; 2009 Oct; 22(10):1032-40. PubMed ID: 19661925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II-receptor antagonist in the treatment of hypertension.
    Volpe M; Tocci G; Pagannone E
    Curr Hypertens Rep; 2005 Aug; 7(4):287-93. PubMed ID: 16061048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease.
    Michel MC; Brunner HR; Foster C; Huo Y
    Pharmacol Ther; 2016 Aug; 164():1-81. PubMed ID: 27130806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin system blocking drugs.
    Robles NR; Cerezo I; Hernandez-Gallego R
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):14-33. PubMed ID: 24038019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin inhibition--benefit beyond hypertension control.
    Kher V
    J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correction of aldosterone level as marker of RAAS dysfunction in patients with arterial hypertension degree II-III and chronic kidney diseases].
    Dralova OV; Maksimov ML; Derbentseva EA; Ermolaeva AS; Starodubtsev AK
    Eksp Klin Farmakol; 2011; 74(4):14-7. PubMed ID: 21678653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving vascular function in hypertension: potential benefits of combination therapy with amlodipine and renin-angiotensin-aldosterone system blockers.
    Siragy HM
    J Hypertens; 2010 Jan; 28(1):2-8. PubMed ID: 19797978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis.
    Tandon P; Abraldes JG; Berzigotti A; Garcia-Pagan JC; Bosch J
    J Hepatol; 2010 Aug; 53(2):273-82. PubMed ID: 20570385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of direct renin inhibitor and angiotensin II receptor blocker on clinic and ambulatory blood pressure profiles in hypertension with chronic kidney disease.
    Uneda K; Tamura K; Wakui H; Azushima K; Haku S; Kobayashi R; Ohki K; Haruhara K; Kinguchi S; Ohsawa M; Fujikawa T; Umemura S
    Clin Exp Hypertens; 2016; 38(8):738-743. PubMed ID: 27936941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newer renin-angiotensin-aldosterone system blocker combinations: is there an advantage?
    Lazich I; Bakris GL
    Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):471-5. PubMed ID: 21709549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete inhibition of the renin-angiotensin-aldosterone system; where do we stand?
    Chen SS; Seliger SL; Fried LF
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):449-55. PubMed ID: 25014549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal protection with angiotensin receptor blockers: where do we stand.
    Schmieder RE; Ruilope LM; Barnett AH
    J Nephrol; 2011; 24(5):569-80. PubMed ID: 21404225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
    Gerc V; Buksa M; Loza V; Kulic M
    Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.